Launching into Early Development: A Recap of Benchling’s Virtual Event
At our Virtual Launch event on September 14, hundreds of R&D and IT professionals from around the world tuned in to learn how we are expanding into the early development market to help companies bring products to market faster. Scientists from the world’s largest pharmaceutical and agricultural giants, new and growing biotechs, and companies throughout the energy, food & beverage, and consumer goods industries all came together with a common purpose: To accelerate product development.
Saji and Ashu – Setting the stage
Benchling’s co-founders, Saji Wickramasekara (CEO) and Ashu Singhal (President), kicked off the event by discussing how the last 18 months have heightened expectations for biotechnology. As Saji put it, “There’s no going back to the protracted timelines of yesterday. We see a universal thread amongst our customers, a commitment to high quality R&D, and they partner with Benchling to accelerate their efforts and get those products to market faster.”
Customer Spotlights: Cue Biopharma and Syngenta – Transforming cancer treatment and agriculture
Cue Biopharma develops novel immunotherapies to treat cancer and auto-immune diseases. Syngenta is developing new and more environmentally-friendly vegetables, field crops, and seeds. Their products are pretty different, but they have a crucial strategy in common: using Benchling to accelerate their development timelines.
Fireside Chat: Dr. Kristen Hege – Bringing cell therapies from concept to clinic
Kristen Hege, M.D., is Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, at Bristol Myers Squibb. Dr. Hege discussed her 30+ year hybrid academic/industry career in cell therapy, from the emergence of the field during the AIDS crisis in the ‘90s, to incredible outcomes in patients with blood cancers in the 2010s, and the approval of the first BCMA CAR T product in 2021.
Announcing two new Benchling product innovations to support development teams
As our customers move products from research into development, we hear time and again that they wish they had the same efficiency, data integrity, and traceability in development that Benchling gives them in research.
Jon Fan, Benchling’s Vice President of Product, discussed the two key themes we hear across this feedback: First, that teams that work in development are very specialized and want to make very complex handoffs amongst teams easier while providing more process context. Second, that development teams need a unique mix of rigidity and flexibility in their process. Because of the regulated nature of development processes, data standardization and control is critical for compliance and analysis.
Jon introduced our newly-redesigned Workflows application, which is now easier-to-use than ever and full of new features to better support handoffs between highly specialized R&D teams. Jon also introduced new Benchling Notebook capabilities – in particular, new functions for more standardized and locked-down templates.
Accelerating progress from research through development
Just as we had an industrial age, an atomic age, and an information age, we’re now entering the century of biotechnology. Decades of work from pioneers like Dr. Hege have brought the world to the edge of a new dawn, where not only CAR T immunotherapies and environmentally-friendly crops, but clean energy, lab-grown meat, biomaterials, and countless other innovations are just around the corner.
To the brilliant minds working on solving our greatest challenges, we thank you for your hard work, your perseverance, and your life-changing technology. We hope we can bring you thoughtful and helpful software as you invent tomorrow. Thank you for building on Benchling.
For a full list of resources related to this launch, visit our Virtual Launch page.
Ready to learn how Benchling can accelerate your R&D?